FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COM
Total 13F shares
31,635,872
Share change
+713,312
Total reported value
$424,146,366
Put/Call ratio
198%
Price per share
$13.40
Number of holders
111
Value change
+$13,926,605
Number of buys
51
Number of sells
46

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q1 2019

As of 31 Mar 2019, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 111 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,635,872 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, BVF INC/IL, BlackRock Inc., GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 111 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.